軟組織修復市場の評価：製品・用途・エンドユーザー・地域別の機会および予測 (2017～2031年)

世界の軟組織修復の市場規模は、2023年の145億1,000万米ドルから、2024年から2031年の予測期間中は4.48%のCAGRで推移し、2031年には206億1,000万米ドルの規模に成長すると予測されています。

同市場の成長を支える主な要因としては、軟組織修復に関連する研究活動を支援する助成金の増加、高齢者人口の増加、スポーツ関連傷害の増加、新規製品の発売などが挙げられます。

さまざまな疾患に対して脆弱となる高齢化人口の増加が軟組織修復ソリューションの需要を増大させています。高齢になると骨密度が低下するため、骨折しやすく、整形外科用修復ソリューションの需要が高まります。さらに、スポーツに関連した怪我の増加も、さまざまな種類の軟組織修復ソリューションの必要性を高めており、市場の成長を支えています。軟組織を修復する技術や製品に対する需要の高まりを受けて、いくつかの大手参入企業や新興企業は、斬新な製品や技術を発表するために多額の投資を行っています。

R&D活動の重要性の高まりが市場の成長を支える

過去数年間、さまざまな大手参入企業や新興企業が技術的に高度な軟組織修復製品の開発を促進するために、R&D活動への投資を増やしてきました。スイスを拠点とする新興企業Regenoscaは、患者の組織移植に代わる非侵襲的なインプラントの開発に携わっています。同社が開発したソリューションは、自家移植による軟組織修復手術を必要とする患者を対象としています。TissueSpanインプラントの助けを借りて、患者は二度目の手術の回避でき、合併症のリスク、手術時間、痛みを軽減することができます。この新興企業のパイプラインにある次の製品は、食道再建用のインプラントで、現在使用されている患者の腸組織や胃に代わるものです。

スポーツ関連傷害の増加と高齢化が市場需要を押し上げる

高齢化社会の拡大とスポーツ関連傷害の増加は、軟組織修復市場の成長を支える主な要因の一つです。スポーツ傷害は一般的に、特定の身体部位への直接的な衝撃や使い過ぎによって発生します。また、身体の一部が構造的に耐えられる以上の力が加わった場合にも起こりえます。Johns Hopkins Medicineによると、およそ3,000万人のティーンエイジャーや子供たちが何らかの組織化されたスポーツに参加しており、毎年350万人以上の怪我が発生しています。

また、高齢化社会では、代謝不全や生理的変化から、さまざまな軟組織の損傷を受けやすくなります。Journal of Abdominal Wall Surgeryによると、鼡径ヘルニアの生涯発生率は女性で3％～6％、男性で27％～43％であり、高齢者での有病率が高いです。このことから、高齢者のヘルニア修復の必要性が高まっています。

当レポートでは、世界の軟組織修復の市場を調査し、市場の定義と概要、市場規模の推移・予測、各種区分・地域別の詳細分析、産業構造、市場成長への影響因子の分析、ケーススタディ、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の軟組織修復市場の展望

• 市場規模・予測
• 製品別
  • 組織固定デバイス
  • 組織パッチ/メッシュ
• 用途別
  • ヘルニア修復
  • 硬膜修復
  • 皮膚修復
  • 整形外科修復
  • 膣スリング
  • 歯科修復
  • 乳房再建修復
  • その他
• エンドユーザー別
  • 病院
  • クリニック
  • 外来手術サービス
• 地域別
  • 北米
  • 欧州
  • 南米
  • アジア太平洋
  • 中東・アフリカ
• 企業別の市場シェア

第5章 世界の軟組織修復市場の展望：地域別

• 北米
• 欧州
• 南米
• アジア太平洋
• 中東・アフリカ

第6章 市場マッピング

• 製品タイプ別
• 用途別
• エンドユーザー別
• 地域別

第7章 マクロ環境と産業構造

• 需給分析
• 輸出入分析
• バリューチェーン分析
• PESTEL分析
• ポーターのファイブフォース分析

第8章 市場力学

• 成長促進要因
• 成長阻害要因 (課題・抑制要因)

第9章 規制の枠組みとイノベーション

• 特許の情勢
• 規制当局の承認
• イノベーション/新興技術

第10章 主要企業の情勢

• 市場リーダー上位5社の競合マトリックス
• 市場リーダー上位5社の市場収益分析
• M&A・ジョイントベンチャー (該当する場合)
• SWOT分析（主要企業）
• 特許分析（該当する場合）

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の見通し

• Arthrex, Inc.
• Baxter International Inc.
• Medtronic
• Boston Scientific Corporation
• Stryker Corporation
• Becton, Dickinson and Company
• Smith & Nephew Plc.
• Zimmer Biomet
• Johnson & Johnson Private Limited
• Integra LifeSciences Corporation

第14章 戦略的提言

第15章 当社について・免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1.Global Soft Tissue Repair Market, By Value, in USD Billion, 2017-2031F
• Figure 2.Global Soft Tissue Repair Market, By Volume, in Million Units, 2017-2031F
• Figure 3.Global Soft Tissue Repair Market Share (%), By Product, 2017-2031F
• Figure 4.Global Soft Tissue Repair Market Share (%), By Application, 2017-2031F
• Figure 5.Global Soft Tissue Repair Market Share (%), By End-user, 2017-2031F
• Figure 6.Global Soft Tissue Repair Market Share (%), By Region, 2017-2031F
• Figure 7.North America Soft Tissue Repair Market, By Value, in USD Billion, 2017-2031F
• Figure 8.North America Soft Tissue Repair Market, By Volume, in Million Units, 2017-2031F
• Figure 9.North America Soft Tissue Repair Market Share (%), By Product, 2017-2031F
• Figure 10.North America Soft Tissue Repair Market Share (%), By Application, 2017-2031F
• Figure 11.North America Soft Tissue Repair Market Share (%), By End-user, 2017-2031F
• Figure 12.North America Soft Tissue Repair Market Share (%), By Country, 2017-2031F
• Figure 13.United States Soft Tissue Repair Market, By Value, in USD Billion, 2017-2031F
• Figure 14.United States Soft Tissue Repair Market, By Volume, in Million Units, 2017-2031F
• Figure 15.United States Soft Tissue Repair Market Share (%), By Product, 2017-2031F
• Figure 16.United States Soft Tissue Repair Market Share (%), By Application, 2017-2031F
• Figure 17.United States Soft Tissue Repair Market Share (%), By End-user, 2017-2031F
• Figure 18.Canada Soft Tissue Repair Market, By Value, in USD Billion, 2017-2031F
• Figure 19.Canada Soft Tissue Repair Market, By Volume, in Million Units, 2017-2031F
• Figure 20.Canada Soft Tissue Repair Market Share (%), By Product, 2017-2031F
• Figure 21.Canada Soft Tissue Repair Market Share (%), By Application, 2017-2031F
• Figure 22.Canada Soft Tissue Repair Market Share (%), By End-user, 2017-2031F
• Figure 23.Mexico Soft Tissue Repair Market, By Value, in USD Billion, 2017-2031F
• Figure 24.Mexico Soft Tissue Repair Market, By Volume, in Million Units, 2017-2031F
• Figure 25.Mexico Soft Tissue Repair Market Share (%), By Product, 2017-2031F
• Figure 26.Mexico Soft Tissue Repair Market Share (%), By Application, 2017-2031F
• Figure 27.Mexico Soft Tissue Repair Market Share (%), By End-user, 2017-2031F
• Figure 28.Europe Soft Tissue Repair Market, By Value, in USD Billion, 2017-2031F
• Figure 29.Europe Soft Tissue Repair Market, By Volume, in Million Units, 2017-2031F
• Figure 30.Europe Soft Tissue Repair Market Share (%), By Product, 2017-2031F
• Figure 31.Europe Soft Tissue Repair Market Share (%), By Application, 2017-2031F
• Figure 32.Europe Soft Tissue Repair Market Share (%), By End-user, 2017-2031F
• Figure 33.Europe Soft Tissue Repair Market Share (%), By Country, 2017-2031F
• Figure 34.Germany Soft Tissue Repair Market, By Value, in USD Billion, 2017-2031F
• Figure 35.Germany Soft Tissue Repair Market, By Volume, in Million Units, 2017-2031F
• Figure 36.Germany Soft Tissue Repair Market Share (%), By Product, 2017-2031F
• Figure 37.Germany Soft Tissue Repair Market Share (%), By Application, 2017-2031F
• Figure 38.Germany Soft Tissue Repair Market Share (%), By End-user, 2017-2031F
• Figure 39.France Soft Tissue Repair Market, By Value, in USD Billion, 2017-2031F
• Figure 40.France Soft Tissue Repair Market, By Volume, in Million Units, 2017-2031F
• Figure 41.France Soft Tissue Repair Market Share (%), By Product, 2017-2031F
• Figure 42.France Soft Tissue Repair Market Share (%), By Application, 2017-2031F
• Figure 43.France Soft Tissue Repair Market Share (%), By End-user, 2017-2031F
• Figure 44.Italy Soft Tissue Repair Market, By Value, in USD Billion, 2017-2031F
• Figure 45.Italy Soft Tissue Repair Market, By Volume, in Million Units, 2017-2031F
• Figure 46.Italy Soft Tissue Repair Market Share (%), By Product, 2017-2031F
• Figure 47.Italy Soft Tissue Repair Market Share (%), By Application, 2017-2031F
• Figure 48.Italy Soft Tissue Repair Market Share (%), By End-user, 2017-2031F
• Figure 49.United Kingdom Soft Tissue Repair Market, By Value, in USD Billion, 2017-2031F
• Figure 50.United Kingdom Soft Tissue Repair Market, By Volume, in Million Units, 2017-2031F
• Figure 51.United Kingdom Soft Tissue Repair Market Share (%), By Product, 2017-2031F
• Figure 52.United Kingdom Soft Tissue Repair Market Share (%), By Application, 2017-2031F
• Figure 53.United Kingdom Soft Tissue Repair Market Share (%), By End-user, 2017-2031F
• Figure 54.Russia Soft Tissue Repair Market, By Value, in USD Billion, 2017-2031F
• Figure 55.Russia Soft Tissue Repair Market, By Volume, in Million Units, 2017-2031F
• Figure 56.Russia Soft Tissue Repair Market Share (%), By Product, 2017-2031F
• Figure 57.Russia Soft Tissue Repair Market Share (%), By Application, 2017-2031F
• Figure 58.Russia Soft Tissue Repair Market Share (%), By End-user, 2017-2031F
• Figure 59.Netherlands Soft Tissue Repair Market, By Value, in USD Billion, 2017-2031F
• Figure 60.Netherlands Soft Tissue Repair Market, By Volume, in Million Units, 2017-2031F
• Figure 61.Netherlands Soft Tissue Repair Market Share (%), By Product, 2017-2031F
• Figure 62.Netherlands Soft Tissue Repair Market Share (%), By Application, 2017-2031F
• Figure 63.Netherlands Soft Tissue Repair Market Share (%), By End-user, 2017-2031F
• Figure 64.Spain Soft Tissue Repair Market, By Value, in USD Billion, 2017-2031F
• Figure 65.Spain Soft Tissue Repair Market, By Volume, in Million Units, 2017-2031F
• Figure 66.Spain Soft Tissue Repair Market Share (%), By Product, 2017-2031F
• Figure 67.Spain Soft Tissue Repair Market Share (%), By Application, 2017-2031F
• Figure 68.Spain Soft Tissue Repair Market Share (%), By End-user, 2017-2031F
• Figure 69.Turkey Soft Tissue Repair Market, By Value, in USD Billion, 2017-2031F
• Figure 70.Turkey Soft Tissue Repair Market, By Volume, in Million Units, 2017-2031F
• Figure 71.Turkey Soft Tissue Repair Market Share (%), By Product, 2017-2031F
• Figure 72.Turkey Soft Tissue Repair Market Share (%), By Application, 2017-2031F
• Figure 73.Turkey Soft Tissue Repair Market Share (%), By End-user, 2017-2031F
• Figure 74.Poland Soft Tissue Repair Market, By Value, in USD Billion, 2017-2031F
• Figure 75.Poland Soft Tissue Repair Market, By Volume, in Million Units, 2017-2031F
• Figure 76.Poland Soft Tissue Repair Market Share (%), By Product, 2017-2031F
• Figure 77.Poland Soft Tissue Repair Market Share (%), By Application, 2017-2031F
• Figure 78.Poland Soft Tissue Repair Market Share (%), By End-user, 2017-2031F
• Figure 79.South America Soft Tissue Repair Market, By Value, in USD Billion, 2017-2031F
• Figure 80.South America Soft Tissue Repair Market, By Volume, in Million Units, 2017-2031F
• Figure 81.South America Soft Tissue Repair Market Share (%), By Product, 2017-2031F
• Figure 82.South America Soft Tissue Repair Market Share (%), By Application, 2017-2031F
• Figure 83.South America Soft Tissue Repair Market Share (%), By End-user, 2017-2031F
• Figure 84.South America Soft Tissue Repair Market Share (%), By Country, 2017-2031F
• Figure 85.Brazil Soft Tissue Repair Market, By Value, in USD Billion, 2017-2031F
• Figure 86.Brazil Soft Tissue Repair Market, By Volume, in Million Units, 2017-2031F
• Figure 87.Brazil Soft Tissue Repair Market Share (%), By Product, 2017-2031F
• Figure 88.Brazil Soft Tissue Repair Market Share (%), By Application, 2017-2031F
• Figure 89.Brazil Soft Tissue Repair Market Share (%), By End-user, 2017-2031F
• Figure 90.Argentina Soft Tissue Repair Market, By Value, in USD Billion, 2017-2031F
• Figure 91.Argentina Soft Tissue Repair Market, By Volume, in Million Units, 2017-2031F
• Figure 92.Argentina Soft Tissue Repair Market Share (%), By Product, 2017-2031F
• Figure 93.Argentina Soft Tissue Repair Market Share (%), By Application, 2017-2031F
• Figure 94.Argentina Soft Tissue Repair Market Share (%), By End-user, 2017-2031F
• Figure 95.Asia-Pacific Soft Tissue Repair Market, By Value, in USD Billion, 2017-2031F
• Figure 96.Asia-Pacific Soft Tissue Repair Market, By Volume, in Million Units, 2017-2031F
• Figure 97.Asia-Pacific Soft Tissue Repair Market Share (%), By Product, 2017-2031F
• Figure 98.Asia-Pacific Soft Tissue Repair Market Share (%), By Application, 2017-2031F
• Figure 99.Asia-Pacific Soft Tissue Repair Market Share (%), By End-user, 2017-2031F
• Figure 100.Asia-Pacific Soft Tissue Repair Market Share (%), By Country, 2017-2031F
• Figure 101.India Soft Tissue Repair Market, By Value, in USD Billion, 2017-2031F
• Figure 102.India Soft Tissue Repair Market, By Volume, in Million Units, 2017-2031F
• Figure 103.India Soft Tissue Repair Market Share (%), By Product, 2017-2031F
• Figure 104.India Soft Tissue Repair Market Share (%), By Application, 2017-2031F
• Figure 105.India Soft Tissue Repair Market Share (%), By End-user, 2017-2031F
• Figure 106.China Soft Tissue Repair Market, By Value, in USD Billion, 2017-2031F
• Figure 107.China Soft Tissue Repair Market, By Volume, in Million Units, 2017-2031F
• Figure 108.China Soft Tissue Repair Market Share (%), By Product, 2017-2031F
• Figure 109.China Soft Tissue Repair Market Share (%), By Application, 2017-2031F
• Figure 110.China Soft Tissue Repair Market Share (%), By End-user, 2017-2031F
• Figure 111.Japan Soft Tissue Repair Market, By Value, in USD Billion, 2017-2031F
• Figure 112.Japan Soft Tissue Repair Market, By Volume, in Million Units, 2017-2031F
• Figure 113.Japan Soft Tissue Repair Market Share (%), By Product, 2017-2031F
• Figure 114.Japan Soft Tissue Repair Market Share (%), By Application, 2017-2031F
• Figure 115.Japan Soft Tissue Repair Market Share (%), By End-user, 2017-2031F
• Figure 116.Australia Soft Tissue Repair Market, By Value, in USD Billion, 2017-2031F
• Figure 117.Australia Soft Tissue Repair Market, By Volume, in Million Units, 2017-2031F
• Figure 118.Australia Soft Tissue Repair Market Share (%), By Product, 2017-2031F
• Figure 119.Australia Soft Tissue Repair Market Share (%), By Application, 2017-2031F
• Figure 120.Australia Soft Tissue Repair Market Share (%), By End-user, 2017-2031F
• Figure 121.Vietnam Soft Tissue Repair Market, By Value, in USD Billion, 2017-2031F
• Figure 122.Vietnam Soft Tissue Repair Market, By Volume, in Million Units, 2017-2031F
• Figure 123.Vietnam Soft Tissue Repair Market Share (%), By Product, 2017-2031F
• Figure 124.Vietnam Soft Tissue Repair Market Share (%), By Application, 2017-2031F
• Figure 125.Vietnam Soft Tissue Repair Market Share (%), By End-user, 2017-2031F
• Figure 126.South Korea Soft Tissue Repair Market, By Value, in USD Billion, 2017-2031F
• Figure 127.South Korea Soft Tissue Repair Market, By Volume, in Million Units, 2017-2031F
• Figure 128.South Korea Soft Tissue Repair Market Share (%), By Product, 2017-2031F
• Figure 129.South Korea Soft Tissue Repair Market Share (%), By Application, 2017-2031F
• Figure 130.South Korea Soft Tissue Repair Market Share (%), By End-user, 2017-2031F
• Figure 131.Indonesia Soft Tissue Repair Market, By Value, in USD Billion, 2017-2031F
• Figure 132.Indonesia Soft Tissue Repair Market, By Volume, in Million Units, 2017-2031F
• Figure 133.Indonesia Soft Tissue Repair Market Share (%), By Product, 2017-2031F
• Figure 134.Indonesia Soft Tissue Repair Market Share (%), By Application, 2017-2031F
• Figure 135.Indonesia Soft Tissue Repair Market Share (%), By End-user, 2017-2031F
• Figure 136.Philippines Soft Tissue Repair Market, By Value, in USD Billion, 2017-2031F
• Figure 137.Philippines Soft Tissue Repair Market, By Volume, in Million Units, 2017-2031F
• Figure 138.Philippines Soft Tissue Repair Market Share (%), By Product, 2017-2031F
• Figure 139.Philippines Soft Tissue Repair Market Share (%), By Application, 2017-2031F
• Figure 140.Philippines Soft Tissue Repair Market Share (%), By End-user, 2017-2031F
• Figure 141.Middle East & Africa Soft Tissue Repair Market, By Value, in USD Billion, 2017-2031F
• Figure 142.Middle East & Africa Soft Tissue Repair Market, By Volume, in Million Units, 2017-2031F
• Figure 143.Middle East & Africa Soft Tissue Repair Market Share (%), By Product, 2017-2031F
• Figure 144.Middle East & Africa Soft Tissue Repair Market Share (%), By Application, 2017-2031F
• Figure 145.Middle East & Africa Soft Tissue Repair Market Share (%), By End-user, 2017-2031F
• Figure 146.Middle East & Africa Soft Tissue Repair Market Share (%), By Country, 2017-2031F
• Figure 147.Saudi Arabia Soft Tissue Repair Market, By Value, in USD Billion, 2017-2031F
• Figure 148.Saudi Arabia Soft Tissue Repair Market, By Volume, in Million Units, 2017-2031F
• Figure 149.Saudi Arabia Soft Tissue Repair Market Share (%), By Product, 2017-2031F
• Figure 150.Saudi Arabia Soft Tissue Repair Market Share (%), By Application, 2017-2031F
• Figure 151.Saudi Arabia Soft Tissue Repair Market Share (%), By End-user, 2017-2031F
• Figure 152.UAE Soft Tissue Repair Market, By Value, in USD Billion, 2017-2031F
• Figure 153.UAE Soft Tissue Repair Market, By Volume, in Million Units, 2017-2031F
• Figure 154.UAE Soft Tissue Repair Market Share (%), By Product, 2017-2031F
• Figure 155.UAE Soft Tissue Repair Market Share (%), By Application, 2017-2031F
• Figure 156.UAE Soft Tissue Repair Market Share (%), By End-user, 2017-2031F
• Figure 157.South Africa Soft Tissue Repair Market, By Value, in USD Billion, 2017-2031F
• Figure 158.South Africa Soft Tissue Repair Market, By Volume, in Million Units, 2017-2031F
• Figure 159.South Africa Soft Tissue Repair Market Share (%), By Product, 2017-2031F
• Figure 160.South Africa Soft Tissue Repair Market Share (%), By Application, 2017-2031F
• Figure 161.South Africa Soft Tissue Repair Market Share (%), By End-user, 2017-2031F
• Figure 162.By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 163.By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 164.By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 165.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

The global soft tissue repair market is projected to witness a CAGR of 4.48% during the forecast period 2024-2031, growing from USD 14.51 billion in 2023 to USD 20.61 billion in 2031. The major factors supporting the growth of the market include increased provision of grants that support research activities related to soft tissue repair, the growing geriatric population, rising incidences of sports-related injuries, and novel product launches.

The growth of the aging population is bolstering the demand for soft tissue repair solutions as they are more susceptible to the requirement of soft tissue repair solutions owing to their vulnerability to various afflictions. As an individual age, the bone mineral density decreases, increasing the occurrence of fractures and propelling the requirement for orthopedic repair solutions. Additionally, increasing incidences of sports related injuries are also supporting the growth of the market as they are boosting the requirement for different types of soft tissue repair solutions. Due to the increasing demand for technologies and products to repair soft tissues, several leading market players and start-ups are heavily investing in launching novel products and technologies.

Various studies are also being conducted by different companies and research institutions to support the development of novel products and assess the safety of existing solutions. For instance, Tissium, a France-based biotechnology company is conducting an interventional study to capture preliminary performance and safety of the Adhesive Hernia Repair System (TAHRS) for Atraumatic Laparoscopic repair of hernia. The study is expected to conclude in December 2024.

Rising Emphasis on Research and Development Activities Support Market Growth

Over the past few years, various leading market players and startups have steadily increased investments in various research and development activities to promote the development of technologically advanced soft tissue repair products. For instance, Regenosca, a Switzerland-based startup is involved with the development of implants that are engineered as a noninvasive alternative to the patient's tissue grafts. The solution developed by the company targets patients who require an autograft soft tissue repair surgery. With the help of TissueSpan implants, patients can avoid having a second surgical site, reducing the risk of complications, surgery time, and pain. The next product in the startup's pipeline is an implant for oesophagus reconstruction to replace the currently used patient's intestinal tissue or stomach.

Various regulatory bodies are also providing clearance for different products and expanding their indications of use. For instance, in 2023, the Food and Drug Administration (FDA) granted 510(k) clearance to three surgical mesh products. This clearance has expanded their indication for use. The intended use of surgical mesh products is the reinforcement of soft tissues where weaknesses exist.

Increasing Incidences of Sports Related Injuries and Aging Population Boost Market Demand

The expansion of the aging population and increasing incidences of sports related injuries are some of the major factors supporting the growth of the soft tissue repair market. Sports injuries commonly occur through direct impact or overuse of a certain body part. It can also occur if the application of force is greater than what the part of the body can structurally withstand. According to Johns Hopkins Medicine, approximately 30 million teenagers and children participate in some type of organized sport and over 3.5 million injuries occur every year. Various times the sports related injury requires that the soft tissues be repaired.

Meanwhile, the aging population is more susceptible to various soft tissue injuries as they go through metabolic inefficiencies and physiological changes. According to the Journal of Abdominal Wall Surgery, the lifetime occurrence of groin hernias is 3%-6% in women and 27%-43% in men, with high prevalence in elderly patients. Thus, propelling the requirement for hernia repair in the elderly.

North America Accounts for Significant Soft Tissue Repair Market Share

The market expansion in North America can be attributed to a wide range of drivers, including rising investments in the healthcare infrastructure, growing incidences of sports related injuries, increasing geriatric population, and strong presence of various leading market players and research institutions. The rise in the number of novel product launches is providing lucrative growth opportunities for the market. The growing investments in different research activities are further bolstering the market growth in the region. For instance, the Cleveland Clinic, Ohio, United States is involved in an interventional study to evaluate the effectiveness of ArthroFLEX(R) ECM scaffold graph for rotator cuff repair surgeries to reduce the rate of failure of rotator cuff repairs for massive and large rotator cuff repairs. The multi-center, randomized, and controlled clinical trial will involve seventy patients, with thirty-five patients being randomly assigned to each arm. The study is expected to be completed in June 2024.

Tissue Patch/Mesh Account for Significant Share of the Market

The segment growth can be attributed to the increasing utilization of synthetic mesh for different orthopedic procedures, including arthritis, owing to their ability to minimize surgery time. According to the data from the National Health Interview Survey (NHIS), during 2019-2021, an approximated 53.2 million adults in the United States were diagnosed with some form of arthritis, including gout, lupus, fibromyalgia, and rheumatoid arthritis. Novel product launches are also supporting the expansion of the segment. For instance, in 2021 Myriad Morcells(TM), a powdered format of Myriad Matrix(TM), received the 10(k) clearance by the FDA. The product was launched by the soft tissue regeneration company, Aroa Biosurgery Limited. The product easily optimizes contact with irregular wound beds.

Orthopedic Repair Segment Witnesses Significant Expansion

The growth of the orthopedic repair segment can be attributed to the increasing geriatric population and rising incidences of sports related injuries. As individuals age, bone mineral density decreases, resulting in increased brittleness of bones, making them more prone to orthopedic injuries. The risk of injury also increases if other health issues, including vision problems and unsteady balance, become more prominent. Due to such factors, the demand for orthopedic soft tissue repair procedures and the development of new products is increasing. Various biotechnology companies are also welcoming experts from the orthopedic industry to strengthen their orthopedic repair segment. For instance, ABANZA a leading Biotechnology company welcomed a new Executive Vice President for US Operations, with notable expertise in the orthopedic industry to ensure the commercialization of their WASHERCAP(TM) Soft Tissue Fixation System. WASHERCAP(TM) is the first in a series of innovative product releases that will focus on soft tissue fixation and repair.

Future Market Scenario (2024 - 2031F)

With the help of their recently secured funding, ZuriMED a Zurich-based biotechnology company, is expected to obtain regulatory approval for their initial product that will focus on repairing shoulder rotator cuff injuries. The company plans on entering the surgical device market in Europe and the United States over the course of three years.

Various research organizations and scientific institutions are being rewarded with funding and grants to support soft tissue restoration, promoting novel research, and supporting the growth of the market. For instance, in 2023, Penn State chemical engineering and reconstructive surgery researchers received a four-year, USD 3 million grant from the National Institutes of Health's National Heart, Lung, and Blood Institute to develop new methods of restoring soft tissue loss in patients with the help of two coordinating revascularization techniques. The team of researchers plans to combine a microsurgical tactic known as vascular micropuncture with a class of protein-based granular hydrogel biomaterials.

Key Players Landscape and Outlook

Key participants in the soft tissue repair market include Arthrex, Inc., Baxter International Inc., Medtronic, Boston Scientific Corporation, and Stryker Corporation. The market expansion is supported by increasing cases of trauma, rising sports related injuries, and growing investments by various organizations towards the development of advanced technological solutions.

In 2023, ZuriMED Technologies, one of the leading biotechnology companies based in Zurich, announced that they raised €15 million for their minimally invasive tech that is expected to transform soft tissue repair. The company plans on using the funds to accelerate the acceptance and advancement of its Surgical-Fiberlock technology, the innovative solution that was specially designed for repairing soft tissues through minimally invasive surgical procedures. The funding round was joined by a group of private investors that included prominent orthopedic surgeons from Germany, Switzerland, France, and the United States and Yellowstone Holding AG and led by Chindex Medical Limited.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Soft Tissue Repair Market Outlook, 2017-2031F

• 4.1.Market Size & Forecast
  • 4.1.1.By Value
  • 4.1.2.By Volume
• 4.2.By Product
  • 4.2.1.Tissue Fixation Devices
    • 4.2.1.1.Sutures
    • 4.2.1.2.Suture Anchors
    • 4.2.1.3.Interference Screws
    • 4.2.1.4.Others
  • 4.2.2.Tissue Patch/ Mesh
    • 4.2.2.1.Synthetic Mesh
    • 4.2.2.2.Biological Mesh
    • 4.2.2.2.1.Xenograft
    • 4.2.2.2.2.Allograft
• 4.3.By Application
  • 4.3.1.Hernia Repair
  • 4.3.2.Dural Repair
  • 4.3.3.Skin Repair
  • 4.3.4.Orthopedic Repair
  • 4.3.5.Vaginal Sling
  • 4.3.6.Dental Repair
  • 4.3.7.Breast Reconstruction Repair
  • 4.3.8.Others
• 4.4.By End-user
  • 4.4.1.Hospitals
  • 4.4.2.Clinics
  • 4.4.3.Ambulatory Surgical Services
• 4.5.By Region
  • 4.5.1.North America
  • 4.5.2.South America
  • 4.5.3.Europe
  • 4.5.4.Asia-Pacific
  • 4.5.5.Middle East & Africa
• 4.6.By Company Market Share (%), 2023

5.Global Soft Tissue Repair Market Outlook, By Region, 2017-2031F

• 5.1.North America*
  • 5.1.1.Market Size & Forecast
    • 5.1.1.1.By Value
    • 5.1.1.2.By Volume
  • 5.1.2.By Product
    • 5.1.2.1.Tissue Fixation Devices
    • 5.1.2.1.1.Sutures
    • 5.1.2.1.2.Suture Anchors
    • 5.1.2.1.3.Interference Screws
    • 5.1.2.1.4.Others
    • 5.1.2.2.Tissue Patch/Mesh
    • 5.1.2.2.1.Synthetic Mesh
    • 5.1.2.2.2.Biological Mesh
    • 5.1.2.2.2.1.Xenograft
    • 5.1.2.2.2.2.Allograft
  • 5.1.3.By Application
    • 5.1.3.1.Hernia Repair
    • 5.1.3.2.Dural Repair
    • 5.1.3.3.Skin Repair
    • 5.1.3.4.Orthopedic Repair
    • 5.1.3.5.Vaginal Sling
    • 5.1.3.6.Dental Repair
    • 5.1.3.7.Breast Reconstruction Repair
    • 5.1.3.8.Others
  • 5.1.4.By End-user
    • 5.1.4.1.Hospitals
    • 5.1.4.2.Clinics
    • 5.1.4.3.Ambulatory Surgical Services
  • 5.1.5.United States*
    • 5.1.5.1.Market Size & Forecast
    • 5.1.5.1.1.By Value
    • 5.1.5.1.2.By Volume
    • 5.1.5.2.By Product
    • 5.1.5.2.1.Tissue Fixation Devices
    • 5.1.5.2.1.1.Sutures
    • 5.1.5.2.1.2.Suture Anchors
    • 5.1.5.2.1.3.Interference Screws
    • 5.1.5.2.1.4.Others
    • 5.1.5.2.2.Tissue Patch/ Mesh
    • 5.1.5.2.2.1.Synthetic Mesh
    • 5.1.5.2.2.2.Biological Mesh
    • 5.1.5.2.2.2.1.Xenograft
    • 5.1.5.2.2.2.2.Allograft
    • 5.1.5.3.By Application
    • 5.1.5.3.1.Hernia Repair
    • 5.1.5.3.2.Dural Repair
    • 5.1.5.3.3.Skin Repair
    • 5.1.5.3.4.Orthopedic Repair
    • 5.1.5.3.5.Vaginal Sling
    • 5.1.5.3.6.Dental Repair
    • 5.1.5.3.7.Breast Reconstruction Repair
    • 5.1.5.3.8.Others
    • 5.1.5.4.By End-user
    • 5.1.5.4.1.Hospitals
    • 5.1.5.4.2.Clinics
    • 5.1.5.4.3.Ambulatory Surgical Services
  • 5.1.6.Canada
  • 5.1.7.Mexico

All segments will be provided for all regions and countries covered

• 5.2.Europe
  • 5.2.1.Germany
  • 5.2.2.France
  • 5.2.3.Italy
  • 5.2.4.United Kingdom
  • 5.2.5.Russia
  • 5.2.6.Netherlands
  • 5.2.7.Spain
  • 5.2.8.Turkey
  • 5.2.9.Poland
• 5.3.Asia-Pacific
  • 5.3.1.India
  • 5.3.2.China
  • 5.3.3.Japan
  • 5.3.4.Australia
  • 5.3.5.Vietnam
  • 5.3.6.South Korea
  • 5.3.7.Indonesia
  • 5.3.8.Philippines
• 5.4.South America
  • 5.4.1.Brazil
  • 5.4.2.Argentina
• 5.5.Middle East & Africa
  • 5.5.1.Saudi Arabia
  • 5.5.2.UAE
  • 5.5.3.South Africa

6.Market Mapping, 2023

• 6.1.By Product
• 6.2.By Application
• 6.3.By End-user
• 6.4.By Region

7.Macro Environment and Industry Structure

• 7.1.Supply Demand Analysis
• 7.2.Import Export Analysis
• 7.3.Value Chain Analysis
• 7.4.PESTEL Analysis
  • 7.4.1.Political Factors
  • 7.4.2.Economic System
  • 7.4.3.Social Implications
  • 7.4.4.Technological Advancements
  • 7.4.5.Environmental Impacts
  • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 7.5.Porter's Five Forces Analysis
  • 7.5.1.Supplier Power
  • 7.5.2.Buyer Power
  • 7.5.3.Substitution Threat
  • 7.5.4.Threat from New Entrant
  • 7.5.5.Competitive Rivalry

8.Market Dynamics

• 8.1.Growth Drivers
• 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

• 9.1.Patent Landscape
• 9.2.Regulatory Approvals
• 9.3.Innovations/Emerging Technologies

10.Key Players Landscape

• 10.1.Competition Matrix of Top Five Market Leaders
• 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
• 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
• 10.4.SWOT Analysis (For Five Market Players)
• 10.5.Patent Analysis (If Applicable)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

• 13.1.Arthrex, Inc.
  • 13.1.1.Company Details
  • 13.1.2.Key Management Personnel
  • 13.1.3.Products & Services
  • 13.1.4.Financials (As reported)
  • 13.1.5.Key Market Focus & Geographical Presence
  • 13.1.6.Recent Developments
• 13.2.Baxter International Inc.
• 13.3.Medtronic
• 13.4.Boston Scientific Corporation
• 13.5.Stryker Corporation
• 13.6.Becton, Dickinson and Company
• 13.7.Smith & Nephew Plc.
• 13.8.Zimmer Biomet
• 13.9.Johnson & Johnson Private Limited
• 13.10.Integra LifeSciences Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14.Strategic Recommendations

15.About Us & Disclaimer